Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Massimo BrecciaGiuliana Alimena Review Article 16 August 2012 Pages: 147 - 157
Bevacizumab-Induced Hypertension Kostas N. SyrigosEleni KarapanagiotouKevin Harrington Review Article 16 August 2012 Pages: 159 - 169
Neovascular Age-Related Macular Degeneration Raymond M. SchiffelersTjitske K. van der VaartGert Storm Review Article 16 August 2012 Pages: 171 - 189
Imatinib: As Adjuvant Therapy for Gastrointestinal Stromal Tumor Mark SanfordLesley J. Scott Adis Profile Report 16 August 2012 Pages: 191 - 192
Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma Sheridan M. HoyKate McKeage Adis Profile Report 16 August 2012 Pages: 193 - 195
Belimumab Efficacy is ‘Mild’ but Market Potential Still Great Ben Weintraub InThought Alert 16 August 2012 Pages: 203 - 205